Cargando…

Shifting emphasis from pharmacogenomics to theragnostics

What will be the role of theragnostic patents in upstream and downstream biomarker research?

Detalles Bibliográficos
Autores principales:	Ozdemir, Vural, Williams-Jones, Bryn, Glatt, Stephen J, Tsuang, Ming T, Lohr, James B, Reist, Christopher
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group US 2006
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7096916/ https://www.ncbi.nlm.nih.gov/pubmed/16900136 http://dx.doi.org/10.1038/nbt0806-942

Ejemplares similares

Pharmacogenomic technologies: a necessary "luxury" for better global public health?
por: Olivier, Catherine, et al.
Publicado: (2011)

Negative Symptoms of Psychosis Correlate with Gene Expression of the Wnt/β-Catenin Signaling Pathway in Peripheral Blood
por: Bousman, Chad A., et al.
Publicado: (2013)

Radiation Dosimetry of Theragnostic Pairs for Isotopes of Iodine in IAZA
por: Jans, Hans-S., et al.
Publicado: (2022)

Theragnostic Aspects and Radioimmunotherapy in Pediatric Tumors
por: Cimini, Andrea, et al.
Publicado: (2020)

Bacteriophages as Solid Tumor Theragnostic Agents
por: Veeranarayanan, Srivani, et al.
Publicado: (2021)

Molecular Imaging and Theragnostics of Thyroid Cancers
por: Giovanella, Luca, et al.
Publicado: (2022)

Aptamers as Theragnostic Tools in Prostate Cancer
por: Cruz-Hernández, Carlos David, et al.
Publicado: (2022)

Designing a post-genomics knowledge ecosystem to translate pharmacogenomics into public health action
por: Dove, Edward S, et al.
Publicado: (2012)

Personalisation of Molecular Radiotherapy through Optimisation of Theragnostics
por: Davis, LauraMay, et al.
Publicado: (2020)

The potential of exosomes as theragnostics in various clinical situations
por: Kang, Ju-Seop
Publicado: (2020)

Nuclear Medicine and Cancer Theragnostics: Basic Concepts
por: Zoi, Vasiliki, et al.
Publicado: (2023)

Methodology in the GBD study of China
por: Lin, Ping-I, et al.
Publicado: (2020)

Necrosis targeted combinational theragnostic approach to treat cancer
por: Ji, Yun, et al.
Publicado: (2014)

Theragnostic ultrasound using microbubbles in the treatment of prostate cancer
por: Lee, Hak Jong, et al.
Publicado: (2016)

Tumor microenvironment-responsive nanoparticles for cancer theragnostic applications
por: Uthaman, Saji, et al.
Publicado: (2018)

Theragnostic potentials of core/shell mesoporous silica nanostructures
por: Ravindran Girija, Aswathy, et al.
Publicado: (2019)

What Is Known about Theragnostic Strategies in Colorectal Cancer
por: Parisi, Alessandro, et al.
Publicado: (2021)

PSMA theragnostics for metastatic castration resistant prostate cancer
por: Song, Hong, et al.
Publicado: (2022)

Microfluidic Fabrication of Gadolinium-Doped Hydroxyapatite for Theragnostic Applications
por: Somoza, Manuel, et al.
Publicado: (2023)

Metabolic Priming as a Tool in Redox and Mitochondrial Theragnostics
por: Pinho, Sónia A., et al.
Publicado: (2023)

Magnetic Dehydrodipeptide-Based Self-Assembled Hydrogels for Theragnostic Applications
por: Carvalho, André, et al.
Publicado: (2019)

A paradigm shift in pharmacogenomics: From candidate polymorphisms to comprehensive sequencing
por: Zhou, Yitian, et al.
Publicado: (2022)

Theragnostic Imaging Using Radiolabeled Antibodies and Tyrosine Kinase Inhibitors
por: Yoshimoto, Mitsuyoshi, et al.
Publicado: (2015)

Prostate-specific membrane antigen-mediated theragnostics in prostate cancer
por: Jeong, Seung-hwan, et al.
Publicado: (2021)

Nanomaterials as Ultrasound Theragnostic Tools for Heart Disease Treatment/Diagnosis
por: Alphandéry, Edouard
Publicado: (2022)

Synthesis and Characterization of Magnetic Composite Theragnostics by Nano Spray Drying
por: Perecin, Caio José, et al.
Publicado: (2022)

Glioma extracellular vesicles for precision medicine: prognostic and theragnostic application
por: Marei, Hany E., et al.
Publicado: (2022)

The Evolving Concepts of Haemodynamic Support: From Pulmonary Artery Catheter to Echocardiography and Theragnostics
por: Figueiredo, Antonio, et al.
Publicado: (2011)

From the Magic Bullet to Theragnostics: Certitudes and Hypotheses, Trying to Optimize the Somatostatin Model
por: Di Stasio, Giuseppe Danilo, et al.
Publicado: (2021)

Pharmacogenetics, Pharmacogenomics and Ayurgenomics for Personalized Medicine: A Paradigm Shift
por: Gupta, Pooja D.
Publicado: (2015)

Theragnostic chromosomal rearrangements in treatment‐naive pancreatic ductal adenocarcinomas obtained via endoscopic ultrasound
por: Murphy, Stephen J., et al.
Publicado: (2021)

Theragnostic Use of Radiolabelled Dota-Peptides in Meningioma: From Clinical Demand to Future Applications
por: Laudicella, Riccardo, et al.
Publicado: (2019)

Optimisation of clinical SPECT imaging with 155Tb for theragnostic radionuclide therapy
por: Cocolios, Thomas Elias, et al.
Publicado: (2016)

The potential theragnostic (diagnostic+therapeutic) application of exosomes in diverse biomedical fields
por: Kim, Yong-Seok, et al.
Publicado: (2018)

Clinical Feasibility Study of Gold Nanoparticles as Theragnostic Agents for Precision Radiotherapy
por: López-Valverde, José Antonio, et al.
Publicado: (2022)

Targeting Copper in Cancer Imaging and Therapy: A New Theragnostic Agent
por: Capriotti, Gabriela, et al.
Publicado: (2022)

Metal and Metal Oxides Nanoparticles and Nanosystems in Anticancer and Antiviral Theragnostic Agents
por: Shabatina, Tatyana I., et al.
Publicado: (2023)

Molecularly imprinted polymers (MIPs): emerging biomaterials for cancer theragnostic applications
por: Kang, Min Seok, et al.
Publicado: (2023)

Clinical Theragnostic Signature of Extracellular Vesicles in Traumatic Brain Injury (TBI)
por: Dey, Anuvab, et al.
Publicado: (2023)

Diagnosis, Management and Theragnostic Approach of Gastro-Entero-Pancreatic Neuroendocrine Neoplasms
por: Piscopo, Leandra, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_0poalavdbtcgt3vi8nbjnojlck